These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 7875022
1. In vitro and in vivo activity of DQ-2556, a new cephalosporin. Ishida Y, Miyazaki S, Yamaguchi K, Goto S. Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022 [Abstract] [Full Text] [Related]
2. In vitro activity of DQ-2556, a new cephalosporin. Fujimoto T, Otani T, Nakajima R, Une T, Osada Y. Antimicrob Agents Chemother; 1986 Oct; 30(4):611-3. PubMed ID: 3539013 [Abstract] [Full Text] [Related]
3. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome. Mitsukude M, Inoue M, Mitsuhashi S. Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801 [Abstract] [Full Text] [Related]
4. In vitro and in vivo activities of DQ-2556 and its mode of action. Tanaka M, Otsuki M, Nishino T. Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128 [Abstract] [Full Text] [Related]
5. In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria. Hafeez S, Izhar M, Ahmed A, Zafar A, Naeem M. J Pak Med Assoc; 2000 Aug; 50(8):250-2. PubMed ID: 10992706 [Abstract] [Full Text] [Related]
6. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S. Drugs Exp Clin Res; 1989 Aug; 15(1):1-10. PubMed ID: 2663406 [Abstract] [Full Text] [Related]
7. [In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study]. Soussy CJ, Chanal M, Derlot E, Goldstein F, Duval J. Pathol Biol (Paris); 1994 Oct; 42(8):754-60. PubMed ID: 7724247 [Abstract] [Full Text] [Related]
8. Antibacterial properties of Ro 13-99041, a long-acting new cephalosporin. Angehrn P, Probst PJ. Chemotherapy; 1981 Oct; 27 Suppl 1():9-14. PubMed ID: 7249797 [Abstract] [Full Text] [Related]
9. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin. Toyosawa T, Miyazaki S, Tsuji A, Yamaguchi K, Goto S. Antimicrob Agents Chemother; 1993 Jan; 37(1):60-6. PubMed ID: 8431019 [Abstract] [Full Text] [Related]
12. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC. Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641 [Abstract] [Full Text] [Related]
13. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae]. Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D. Rev Med Chir Soc Med Nat Iasi; 2003 Jul 30; 107(3):595-8. PubMed ID: 14756068 [Abstract] [Full Text] [Related]
14. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Neu HC, Aswapokee N, Aswapokee P, Fu KP. Antimicrob Agents Chemother; 1979 Feb 30; 15(2):273-81. PubMed ID: 426518 [Abstract] [Full Text] [Related]
20. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital. Dyke JW, Angones D, Bhakta D, Tenjarla G, Kumar A. Chemotherapy; 1993 Jun 30; 39(5):315-21. PubMed ID: 8370322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]